Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Physicians offer several promising and unique approaches to brain tumor treatment

An estimated 41,000 new cases of primary brain tumors are expected to be diagnosed in 2004, according to the American Brain Tumor Association.

5 Aug 2004

ASTRO and ACS join to promote cancer survivorship

As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Therapeutic Radiology and Oncology is partnering with the Atlanta chapter of the American Cancer Society to raise awareness of cancer survivorship.

5 Aug 2004

Successfully cloning mice from an advanced melanoma cell

Nature can reset the clock in certain types of cancer and reverse many of the elements responsible for causing malignancy, reports a research team led by Whitehead Institute Member Rudolf Jaenisch, in collaboration with Lynda Chin from Dana Farber Cancer Institute.

3 Aug 2004

New Drug Application with the U.S. Food and Drug Administration for Tarceva

OSI Pharmaceuticals and Genentech have announced that OSI completed the submission of a New Drug Application with the U.S. Food and Drug Administration for Tarceva (erlotinib HCl),

3 Aug 2004

Recommendation against the use of chemotherapy sensitivity and resistance assays

A new technology assessment from the American Society of Clinical Oncology states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.

3 Aug 2004

Adhering to established guidelines improves survival and reduces the risk of breast cancer

The first study to compare survival between women with breast cancer whose treatment was based on consensus guidelines and those whose treatment was not shows that adhering to established guidelines improves survival and reduces the risk of recurrence.

3 Aug 2004

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure

29 Jul 2004

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

New research by Mieke Kriege at the Department of Medical Oncology, Rotterdam Family Cancer Clinic suggests that women with a history of cancer in their family are better off having MRI scans instead of mammogram's.

28 Jul 2004

Light-sensitive probe to help doctors spot breast cancer

A light-sensitive probe is being developed to help doctors spot breast cancer in some of the 70,000 American women each year whose malignancies fail to show up in needle biopsies.

26 Jul 2004

Preliminary tests of the new method, which can detect cancer in a sample with as few as 50 cells

Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our genetic code.

23 Jul 2004

ImClone quarterly sales reach $71.4 Million

Total revenues for the second quarter of 2004 were $71.5 million as compared with $17.9 million for the second quarter of 2003 and $109.6 million in the first quarter of 2004.

22 Jul 2004

Bladder-sparing treatment shows promise against cancer

For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a reconstructed bladder or urostomy bag.

21 Jul 2004

Study finds that physicians help patients quit smoking but could provide more education

Physicians are an important resource in New Jerseyans’ fight to stop smoking, but they can and should become even more effective educators, according to a survey by the Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

New compound that is designed to overcome Gleevec resistance

One of the truly spectacular success stories in modern oncology is the development and implementation of Gleevec, a drug that virtually halts the progress of chronic myeloid leukemia. Yet for some patients who harbor particularly stubborn genetic mutations, Gleevec fails miserably.

17 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Research may help predict risk for prostate cancer based on gene expression patterns

According to a study published in the July 15 issue of the Journal of Clinical Oncology, genes expressed in benign tissue adjacent to prostate cancer tissue are much more similar to those expressed in prostate cancer tissue than previously thought.

15 Jul 2004

Oncology News and Research

Further Reading

Physicians offer several promising and unique approaches to brain tumor treatment

ASTRO and ACS join to promote cancer survivorship

Successfully cloning mice from an advanced melanoma cell

New Drug Application with the U.S. Food and Drug Administration for Tarceva

Recommendation against the use of chemotherapy sensitivity and resistance assays

Adhering to established guidelines improves survival and reduces the risk of breast cancer

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Light-sensitive probe to help doctors spot breast cancer

Preliminary tests of the new method, which can detect cancer in a sample with as few as 50 cells

ImClone quarterly sales reach $71.4 Million

Bladder-sparing treatment shows promise against cancer

Study finds that physicians help patients quit smoking but could provide more education

A new vaccine that may delay cancer recurrence

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

New compound that is designed to overcome Gleevec resistance

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Research may help predict risk for prostate cancer based on gene expression patterns

Cancer Research eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News